Thermostable FGF2 Polypeptide, Use Thereof

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F20%3A00114963" target="_blank" >RIV/00216224:14310/20:00114963 - isvavai.cz</a>

Result on the web

<a href="https://worldwide.espacenet.com/patent/search/family/054754475/publication/EP3380508B1?q=pn%3DEP3380508B1" target="_blank" >https://worldwide.espacenet.com/patent/search/family/054754475/publication/EP3380508B1?q=pn%3DEP3380508B1</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Thermostable FGF2 Polypeptide, Use Thereof

Original language description

The present invention relates to engineered Fibroblast Growth Factor 2 (FGF2, bFGF) having improved thermal stability compared to the wild-type and the use thereof in the cell biology research, regenerative medicine and related medical applications or cosmetics. The present invention further relates to a culture medium comprising FGF2 suitable for culturing a human pluripotent stem cells involving both human embryonic stem cells and induced pluripotent stem cells.

Czech name

—

Czech description

—

Type

P - Patent

CEP classification

—

OECD FORD branch

10600 - Biological sciences

Project

<a href="/en/project/LO1214" target="_blank" >LO1214: Research Centre for Toxic Compounds in the Environment</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2020

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID

EP3380508

Publisher

EPO_1 -

Publisher name

European Patent Office

Place of publication

Munich, The Hague, Berlin, Vienna, Brussels

Publication country

—

Date of acceptance

Jul 22, 2020

Owner name

Masarykova univerzita; Enantis s.r.o.

Method of use

A - Výsledek využívá pouze poskytovatel

Usage type

A - K využití výsledku jiným subjektem je vždy nutné nabytí licence